comparemela.com
Latest Breaking News On - Meeting of the myotonic dystrophy foundation - Page 1 : comparemela.com
AMO Pharma Announces Affirming Data from REACH-CDM Clinical Trial for AMO-02 in Treatment of Myotonic Dystrophy
Results to be reviewed during 2023 Myotonic Dystrophy Annual Conference show statistically and clinically significant efficacy benefits in multipl.
London
City-of
United-kingdom
Washington
United-states
New-zealand
Australia
Canada
Kaitlin-gallagher
Meeting-of-the-myotonic-dystrophy-foundation
Pharma-limited
Berry-company-public-relations
vimarsana © 2020. All Rights Reserved.